Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

The first leukaemia patient to receive a breakthrough treatment since it was made available on the NHS has said it was ...

The first leukaemia patient receives a breakthrough treatment since it was made available on the NHS and commented that it ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

Better treatment options have improved survival rates in the U.S., according to a report from the American Cancer Society.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer is undetectable. This is the first phase. Most patients receive a "triplet" ...

KAIST researchers unveil a new cancer therapy that reprograms immune cells inside tumours, eliminating lab-based CAR ...

Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...

An oncology pharmacist shares how a treatment takes a different approach to treating chronic graft-versus-host disease (GVHD) ...

Hodgkin lymphoma and other malignancies that express the CD30 protein have long challenged oncologists, and a new therapy, ...